Virax Biolabs announces extraordinary shareholder meeting
Reuters2026/07/31 11:45- Virax Biolabs will hold an extraordinary general meeting in Glasgow on Aug. 14, 2026.
- Shareholders will vote on increasing authorized share capital to US$12.5 million, or 500,000,000 ordinary shares, from US$50,000, or 2,000,000 shares.
- A separate vote will seek adoption of amended and restated memorandum and articles of association to reflect the share capital increase.
- Another resolution would allow the meeting to be adjourned if more time is needed to secure votes on the proposals.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
JPMorgan resumes coverage of Lithium Americas (LAC.US) and upgrades to "Overweight", target price of $6.
Lithium Americas (LAC.US) shares rose 6% on Wednesday after JPMorgan resumed coverage and raised its rating to "Overweight" with a target price of $6.
Charlie Hospital Semarang says no material information behind share-price volatility
Venteny Fortuna International files corrected annual public expose materials
Abu Dhabi Mubadala Strategic Investment in Luckin Coffee Explained: Transfer of Preferred Shares by New and Old Funds, Transaction Size Around 1 billion USD
The beneficial ownership of Dachen remains unchanged.
Crypto prices
More
